Accord BioPharma
Roivant Halts Lung Disease Drug Development as Bio-Thera and Intas Forge Biosimilar Partnership
Roivant Sciences, namilumab, pulmonary sarcoidosis, Bio-Thera Solutions, Intas Pharmaceuticals, golimumab biosimilar, BAT2506, Accord BioPharma